Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke

Smoking is a leading cause of morbidity and premature mortality among people living with HIV (PLHIV), who have high rates of tobacco smoking. Vaporised nicotine products (VNPs) are growing in popularity as a quit aid and harm reduction tool. However, little is known about their acceptability and use...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Stephanie, Dean, Judith, Gilks, Charles, Boyd, Mark A., Fitzgerald, Lisa, Mutch, Allyson, Baker, Peter, Neilsen, Graham, Gartner, Coral E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Concept Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551237/
https://www.ncbi.nlm.nih.gov/pubmed/28718828
http://dx.doi.org/10.3390/ijerph14070799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551237/
https://www.ncbi.nlm.nih.gov/pubmed/28718828
http://dx.doi.org/10.3390/ijerph14070799

Ejemplares similares